Skip to main content
Tech.euFundingExplorerBeta

Resistomap

Resistomap has a unique knowledge on the combination of microbial antibiotic resistance, molecular genetics and data science.

Resistomap has raised €2.0M across 1 funding round from 1 investor, most recently a Seed round in Nov 2023. Based in Helsinki, Finland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€2.0M
€2,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2023-11
latest 2023-11

Funding by year

EUR raised per year
Resistomap — funding by year — interactive chart.
Data table
Resistomap — funding by year
2023€2.0M

Signals

High confidence
Raise-next likelihood8
base rate 44% for Seed
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2023-11-15Seed€2.0MAnanda Impact VenturesView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData